1. Home
  2. SNEX vs HAE Comparison

SNEX vs HAE Comparison

Compare SNEX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNEX
  • HAE
  • Stock Information
  • Founded
  • SNEX 1924
  • HAE 1971
  • Country
  • SNEX United States
  • HAE United States
  • Employees
  • SNEX N/A
  • HAE N/A
  • Industry
  • SNEX Investment Bankers/Brokers/Service
  • HAE Medical/Dental Instruments
  • Sector
  • SNEX Finance
  • HAE Health Care
  • Exchange
  • SNEX Nasdaq
  • HAE Nasdaq
  • Market Cap
  • SNEX 4.1B
  • HAE 3.3B
  • IPO Year
  • SNEX 1994
  • HAE 1991
  • Fundamental
  • Price
  • SNEX $94.52
  • HAE $75.24
  • Analyst Decision
  • SNEX Buy
  • HAE Strong Buy
  • Analyst Count
  • SNEX 1
  • HAE 10
  • Target Price
  • SNEX N/A
  • HAE $99.00
  • AVG Volume (30 Days)
  • SNEX 419.3K
  • HAE 577.2K
  • Earning Date
  • SNEX 08-05-2025
  • HAE 08-07-2025
  • Dividend Yield
  • SNEX N/A
  • HAE N/A
  • EPS Growth
  • SNEX 17.88
  • HAE 44.54
  • EPS
  • SNEX 5.90
  • HAE 3.31
  • Revenue
  • SNEX $121,723,000,000.00
  • HAE $1,360,824,000.00
  • Revenue This Year
  • SNEX N/A
  • HAE N/A
  • Revenue Next Year
  • SNEX $4.08
  • HAE $7.26
  • P/E Ratio
  • SNEX $16.04
  • HAE $22.68
  • Revenue Growth
  • SNEX 68.26
  • HAE 3.96
  • 52 Week Low
  • SNEX $47.69
  • HAE $55.30
  • 52 Week High
  • SNEX $99.08
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • SNEX 58.54
  • HAE 55.89
  • Support Level
  • SNEX $90.05
  • HAE $72.83
  • Resistance Level
  • SNEX $96.38
  • HAE $75.53
  • Average True Range (ATR)
  • SNEX 2.72
  • HAE 2.04
  • MACD
  • SNEX -0.10
  • HAE -0.34
  • Stochastic Oscillator
  • SNEX 49.50
  • HAE 40.41

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: